Search research articles

Search research articles

Related Experiment Videos

Cell proliferation and renal carcinogenesis

¹Department of Toxicology-U.S., SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.

Environmental Health Perspectives

|December 1, 1993

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Apoptosis in the kidney: a toxicologic pathologist's perspective.

Toxicologic pathology·1998

Same author

The age-related increase in renal clusterin mRNA is accelerated in obese Zucker rats.

Journal of the American Society of Nephrology : JASN·1998

Same author

Automated double labeling of proliferation and apoptosis in glutathione S-transferase-positive hepatocytes in rats.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·1997

Same author

SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent.

The Journal of pharmacology and experimental therapeutics·1995

Same author

Critique of R. Melnick's "An alternative hypothesis on the role of chemically induced protein droplet (alpha 2u-globulin) nephropathy in renal carcinogenesis".

Regulatory toxicology and pharmacology : RTP·1993

Same author

Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

British journal of pharmacology·1993

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cell proliferation plays a key role in kidney tumor development, influenced by both genotoxic and non-genotoxic carcinogens. Understanding these mechanisms is crucial for renal carcinogenesis research.

Area of Science:

Nephrology
Toxicology
Oncology

Background:

Cell proliferation is a critical factor in renal tumorigenesis, occurring during both initiation and progression stages.
Genotoxic carcinogens like dimethylnitrosamine (DMN) induce DNA damage and initial cell proliferation.
Sustained cell proliferation, particularly from non-genotoxic carcinogens like unleaded gasoline and d-limonene, is linked to alpha 2u-globulin (alpha G) nephropathy in male rats.

Purpose of the Study:

To investigate the role of cell proliferation in different stages of renal tumorigenesis.
To explore the mechanisms by which genotoxic and non-genotoxic agents influence renal cell proliferation and tumor development.
To examine the correlation between cell proliferation rates and the incidence of renal preneoplastic and neoplastic lesions.

Main Methods:

Related Experiment Videos

Studies involving genotoxic carcinogens (DMN) with and without pre-existing kidney conditions (unilateral nephrectomy, hydronephrosis).
Investigations using non-genotoxic carcinogens (unleaded gasoline, d-limonene) in specific rat models (male F344, female F344, alpha G deficient NBR rats).
Initiation-promotion experiments to correlate cell proliferation dose-response with tumor incidence.

Main Results:

Genotoxic initiation by DMN is enhanced by conditions causing cell proliferation.
Sustained proliferation induced by non-genotoxic agents is dependent on alpha G complex formation and specific to male rats.
A strong correlation was observed between cell proliferation levels and the occurrence of preneoplastic and neoplastic lesions.

Conclusions:

Cell proliferation is a significant factor in both the initiation and promotion phases of renal carcinogenesis.
Mechanisms of cell proliferation vary depending on the type of carcinogen (genotoxic vs. non-genotoxic).
Further research is needed to elucidate the precise role of cell proliferation in renal carcinogenesis and its relationship with other kidney conditions.